CP-HEM-A303 Lymphoma Leukemia Panel Selection (HEM)__uncontrolled_copy.pdf
PDF 3 MB Posted
- Solicitation number
- 832022
- Issued by
-
Department of the Army Medical Command
About this file
This solicitation amendment extends the closing date for solicitation number 832022 to August 3, 2022. The purpose of the amendment is to incorporate a revised statement of work, include answers to questions received, and attach additional documentation regarding medical device assessment and lymphoma/leukemia panel selection. The solicitation seeks cost-per-test flow cytometry testing services including reagents and instrumentation from the Department of the Army Medical Command. Responses are due by 4:00 PM Central Standard Time on the newly extended closing date of August 3, 2022.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Solicitation Amendment 0001 W81K0022Q0109.pdf | ||
| SSEB - Vol 2 Technical - RMF Questionnaire.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Cur re nt a s o f 2
6- Ju l-2
:4
CP-HEM.A303 Lymphoma Leukemia Panel Selection (HEM)
Copy of version 3.0 (approved and current)
Last Approval or Periodic Review Completed 4/5/2021
Next Periodic Review Needed On or Before 4/5/2023
Effective Date 4/19/2021
Uncontrolled Copy printed on 26-Jul-2022 12:41
Organization Brooke Army Medical Center
(BAMC)
Approval and Periodic Review Signatures
Type Description Date Version Performed By Notes
Approval Captured outside MediaLab
Lab Director 4/5/2021 3.0 Samantha Butler
Recorded on 12/14/2021 by Jeremy Hershfield when document added to MediaLab
Periodic review Captured outside MediaLab
Designated Reviewer 4/5/2021 3.0 Samantha
Butler Recorded on 12/14/2021 by Jeremy Hershfield when document added to MediaLab
Signatures from prior revisions are not listed.
Approvals and periodic reviews that occurred before this document was added to the MediaLab Document Control system may not be listed.
Version History
Version Status Type Date Added Date Effective Date Retired
3.0 Approved and Current First version in Document Control 12/14/2021 4/19/2021 Indefinite
Linked Documents
• CP-HEM.303 Leukemia / Lymphoma Panel (HEM)
CP-HEM.A303 Lymphoma Leukemia Panel Selection (HEM). (version 3.0) Approved and current. Effective starting 4/19/2021.
Uncontrolled copy printed by Ronnie Heflin on 26-Jul-2022 12:41 (CDT). Page 1 of 2
Cur re nt a s o f 2
6- Ju l-2
:4
Lymphoma/Leukemia Panel Selection:
Defer to resident or staff pathologist to determine which panels to run if
1. WBC count is <0.3 x 103/ul and/or volume is <1 ml
2. Two of the following clinical history components are given (ie: CLL and monocytosis)
3. Clinical history is not legible or is otherwise unclear
Clinical History: Panels to Run:
Lymphocytosis Lymphoma + K/L CD5 tube Chronic lymphocytic leukemia (CLL/SLL), Mantle Cell lymphoma, Diffuse large B-cell lymphoma
Lymphoma + K/L CD5 tube
Lymphadenopathy Lymphoma + K/L CD5 tube
Hodgkin lymphoma Lymphoma + K/L CD5 tube LGL Large granular lymphocytes Lymphoma + K/L CD5+ LGL tube Multiple Myeloma, Plasma cell myeloma, or Plasma cell dyscrasia
Lymphoma + K/L CD5 + Plasma cell tube + cytoplasmic K/L
Waldenstroms, Lymphoplasmacytic lymphoma, or marginal zone lymphoma
Lymphoma + K/L CD5 + Plasma cell tube + cytoplasmic K/L
New acute leukemia Leukemia + K/L CD5 tube+ cMPO/TdT/CD19/CD3
If Flow detects: Then add on:
>10% monocytes Monocyte tube CD5-CD10- monoclonal B-cell population in blood or bone marrow
Hairy cell tube + Plasma cell tube + cytoplasmic K/L
CD5-CD10- monoclonal B-cell population in lymph node or mass forming lesion
Plasma cell tube + cytoplasmic K/L
>5% CD34+ or CD117+ blasts cytoplasmic MPO/TdT/CD19/CD3
CP-HEM.A303 Lymphoma Leukemia Panel Selection (HEM). (version 3.0) Approved and current. Effective starting 4/19/2021.
Uncontrolled copy printed by Ronnie Heflin on 26-Jul-2022 12:41 (CDT). Page 2 of 2
File details come from the government source that posted it. Updated .